in Aerospace

Element supports UK ventilator initiative with free EMC and safety testing

Posted 2 April 2020 · Add Comment

Element Materials Technology (Element) is lending its support to the national drive to increase ventilator production in response to the NHS’ urgent demand to treat coronavirus patients in the UK, with a testing regime to cover the electromagnetic compatibility (EMC) and basic safety requirements for a Rapidly Manufactured Ventilator System (RMVS) prototype being developed by a number of manufacturers and consortia.


Courtesy Element


Before new devices can be categorised as ‘safe’ for use in medical working environments and brought to market, it is necessary to determine if a device can perform safely and provide its essential performance without causing harm and/or electromagnetic disturbances in its appropriate operating environment. This is typically achieved by testing to applicable medical safety standards.

Safety test plans drawn up by Element’s Advisory Services team based in Malvern are being used to perform the testing from its product qualification testing (PQT) laboratory in Hitchin. Element also provided EMC test plans to manufacturers who will carry out the initial phase of testing, while phase two testing will be carried out by Element from a number of its PQT facilities.

Mark Heaven, Divisional Director Global Aerospace PQT at Element said: “We are delighted to be able to offer our expertise, free of charge, to support the national effort to fight COVID-19, and are already in discussions with other medical device manufacturers to carry out EMC and safety testing on their RMVS prototypes this week. Element hopes to continue to offer our integral safety conformity services throughout this period of high demand for ventilators.”

Element Hitchin is one of the company's safety testing centres of excellence, with UKAS accreditation to BS EN ISO/IEC 17025:2005. Its areas of technical expertise at Element Hitchin include Medical Testing & Regulatory Affairs, Safety Testing and Certifications & Approvals. It works with manufacturers of electrical medical devices which are approved to ISO 9001:2008 and typically provide medical regulatory testing and test reports to European EN 60601 series of standards and American pre-market authorisations for the 510(k) route, which are the core standards/procedures for medical product verification.

 

 

Other Stories
Advertisement
Latest News

PM to announce largest military investment in 30 years

The biggest programme of investment in British defence since the end of the Cold War will be announced today by the Prime Minister Boris Johnson.

Security & Policing 2021 registration opens for online event

Visitor and exhibitor registration is now open for the official UK Government global security event Security & Policing 2021, set to take place as an online event between 9th-11th March 2021, offering the opportunity to meet,

UK scientists step closer to revealing origins of our Galaxy

Astronomers have today taken a meteoric leap closer to discovering how our solar system began, unveiling the most detailed atlas of the Milky Way in history.

Tech accelerator announces industry partnership with Steatite

Worcestershire’s commercial technology accelerator based at Malvern Hills Science Park, BetaDen, is offering a package worth around £50,000 to develop and commercialise new technology, including for aerospace, defence and

NP Aerospace launches new 4030 ELITE Bomb Disposal Suit

Global armour manufacturer, NP Aerospace, has extended its Explosive Ordnance Disposal (EOD) portfolio with the launch of a next generation Bomb Disposal Suit targeting North America and other strategic global markets.

Resonate Testing partners with Composites Testing Laboratory

Newry based testing company, Resonate Testing Ltd., has partnered with Composites Testing Laboratory (CTL) in Galway to help increase their services and capabilities, as part of ambitious plans by both companies for future growth.

ODU 0201311219
See us at
Security & Policing 2021 BTRAF Museum BT3CDSE BT0210030221